Insider Transactions in Q4 2022 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
20,000
-9.84%
|
$1,000,000
$50.09 P/Share
|
|
Dec 05
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.8%
|
$160,000
$8.44 P/Share
|
|
Nov 03
2022
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
1,100
+1.18%
|
$47,300
$43.98 P/Share
|
|
Nov 03
2022
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
533
-1.21%
|
$23,985
$45.24 P/Share
|
|
Oct 04
2022
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
3,477
-6.18%
|
$232,959
$67.3 P/Share
|